Shanghai OriginCell Therapeutics Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shanghai OriginCell Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC) (NCT04919616) | Shanghai OriginCell Therapeutics Co., Ltd. | 2021-06-15 |
| TILs for Treatment of Metastatic or Recurrent Cervical Cancer (NCT04674488) | Shanghai OriginCell Therapeutics Co., Ltd. | 2020-12-09 |
Track Shanghai OriginCell Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.